{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:31:25Z","timestamp":1772166685390,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82001778"],"award-info":[{"award-number":["82001778"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Capital Medical Development Research Fund","award":["2020-2-1072"],"award-info":[{"award-number":["2020-2-1072"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Neurosurg Jl"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>As molecular advances have deepened the knowledge on low-grade glioma (LGG), we investigated the effect of higher radiation dose on the survival of IDH-wildtype (IDHwt) LGG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In the current study, 52 IDHwt LGG patients who received radiotherapy were enrolled from the Chinese Glioma Genome Atlas dataset. Radiation doses &gt; 54 Gy were defined as high-dose, whereas doses \u2264 54 Gy were defined as low-dose. We performed univariate and multivariate survival analyses to examine the prognostic role of high-dose radiotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, the radiation dose ranged from 48.6 Gy to 61.2 Gy, with a median of 55.8 Gy, and 31 patients were grouped into high-dose radiation. Univariate survival analysis indicated that high-dose radiotherapy (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.015), tumors located in the frontal lobe (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.009), and pathology of astrocytoma (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.037) were significantly prognostic factors for overall survival. In multivariate survival analysis, high-dose radiotherapy (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.028) and tumors located in the frontal lobe (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.016) were independently associated with better overall survival.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In conclusion, high-dose radiotherapy independently improved the survival of IDHwt LGG. This can guide treatments for glioma with known molecular characteristics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41016-021-00239-z","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T04:03:39Z","timestamp":1617249819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["High-dose radiation associated with improved survival in IDH-wildtype low-grade glioma"],"prefix":"10.1186","volume":"7","author":[{"given":"Shuai","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanzhang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoguang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"issue":"26","key":"239_CR1","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","volume":"372","author":"JE Eckel-Passow","year":"2015","unstructured":"Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, Pekmezci M, Rice T, Kosel ML, Smirnov IV, Sarkar G, Caron AA, Kollmeyer TM, Praska CE, Chada AR, Halder C, Hansen HM, McCoy LS, Bracci PM, Marshall R, Zheng S, Reis GF, Pico AR, O\u2019Neill BP, Buckner JC, Giannini C, Huse JT, Perry A, Tihan T, Berger MS, Chang SM, Prados MD, Wiemels J, Wiencke JK, Wrensch MR, Jenkins RB. Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med. 2015;372(26):2499\u2013508. https:\/\/doi.org\/10.1056\/NEJMoa1407279.","journal-title":"N Engl J Med"},{"issue":"26","key":"239_CR2","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","volume":"372","author":"DJ Brat","year":"2015","unstructured":"Cancer Genome Atlas Research N, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med. 2015;372(26):2481\u201398. https:\/\/doi.org\/10.1056\/NEJMoa1402121.","journal-title":"N Engl J Med"},{"issue":"6","key":"239_CR3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131(6):803\u201320. https:\/\/doi.org\/10.1007\/s00401-016-1545-1.","journal-title":"Acta Neuropathol"},{"key":"239_CR4","doi-asserted-by":"publisher","unstructured":"Nabors LB, Portnow J, Ahluwalia M, et al. Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology[J], J Natl Compr Canc Netw. 2020;18(11):1537\u201370. https:\/\/doi.org\/10.6004\/jnccn.2020.0052.","DOI":"10.6004\/jnccn.2020.0052"},{"issue":"2","key":"239_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.canlet.2016.01.024","volume":"375","author":"T Jiang","year":"2016","unstructured":"Jiang T, Mao Y, Ma W, Mao Q, You Y, Yang X, Jiang C, Kang C, Li X, Chen L, Qiu X, Wang W, Li W, Yao Y, Li S, Li S, Wu A, Sai K, Bai H, Li G, Chen B, Yao K, Wei X, Liu X, Zhang Z, Dai Y, Lv S, Wang L, Lin Z, Dong J, Xu G, Ma X, Cai J, Zhang W, Wang H, Chen L, Zhang C, Yang P, Yan W, Liu Z, Hu H, Chen J, Liu Y, Yang Y, Wang Z, Wang Z, Wang Y, You G, Han L, Bao Z, Liu Y, Wang Y, Fan X, Liu S, Liu X, Wang Y, Wang Q, Chinese Glioma Cooperative Group (CGCG). CGCG clinical practice guidelines for the management of adult diffuse gliomas. Cancer letters. 2016;375(2):263\u201373. https:\/\/doi.org\/10.1016\/j.canlet.2016.01.024.","journal-title":"Cancer letters"},{"issue":"3","key":"239_CR6","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/s0360-3016(96)00352-5","volume":"36","author":"AB Karim","year":"1996","unstructured":"Karim AB, Maat B, Hatlevoll R, Menten J, Rutten EH, Thomas DG, et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys. 1996;36(3):549\u201356. https:\/\/doi.org\/10.1016\/s0360-3016(96)00352-5.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"239_CR7","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1200\/JCO.2002.09.126","volume":"20","author":"E Shaw","year":"2002","unstructured":"Shaw E, Arusell R, Scheithauer B, O\u2019fallon J, O\u2019neill B, Dinapoli R, et al. Prospective randomized trial of low-versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group\/Radiation Therapy Oncology Group\/Eastern Cooperative Oncology Group study. J Clin Oncol. 2002;20(9):2267\u201376. https:\/\/doi.org\/10.1200\/JCO.2002.09.126.","journal-title":"J Clin Oncol"},{"issue":"8","key":"239_CR8","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJMoa0808710","volume":"360","author":"H Yan","year":"2009","unstructured":"Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD. IDH1 and IDH2 mutations in gliomas. N Engl J Med. 2009;360(8):765\u201373. https:\/\/doi.org\/10.1056\/NEJMoa0808710.","journal-title":"N Engl J Med"},{"issue":"8","key":"239_CR9","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1093\/neuonc\/now021","volume":"18","author":"P Yang","year":"2016","unstructured":"Yang P, Cai J, Yan W, Zhang W, Wang Y, Chen B, Li G, Li S, Wu C, Yao K, Li W, Peng X, You Y, Chen L, Jiang C, Qiu X, Jiang T, CGGA project. Classification based on mutations of TERT promoter and IDH characterizes subtypes in grade II\/III gliomas. Neuro-oncology. 2016;18(8):1099\u2013108. https:\/\/doi.org\/10.1093\/neuonc\/now021.","journal-title":"Neuro-oncology"},{"issue":"1","key":"239_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030339","volume":"7","author":"W Yan","year":"2012","unstructured":"Yan W, Zhang W, You G, Bao Z, Wang Y, Liu Y, Kang C, You Y, Wang L, Jiang T. Correlation of IDH1 mutation with clinicopathologic factors and prognosis in primary glioblastoma: a report of 118 patients from China. PLoS One. 2012;7(1):e30339. https:\/\/doi.org\/10.1371\/journal.pone.0030339.","journal-title":"PLoS One"},{"issue":"6","key":"239_CR11","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1136\/jnnp.2004.048520","volume":"76","author":"H Duffau","year":"2005","unstructured":"Duffau H, Lopes M, Arthuis F, Bitar A, Sichez J, Van Effenterre R, et al. Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: a comparative study between two series without (1985\u201396) and with (1996\u20132003) functional mapping in the same institution. J Neurol Neurosurg Psychiatry. 2005;76(6):845\u201351. https:\/\/doi.org\/10.1136\/jnnp.2004.048520.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"239_CR12","doi-asserted-by":"publisher","unstructured":"Stummer W, Reulen HJ, Novotny A, Steppe H, Tonn JC. Fluorescence-guided resections of malignant gliomas \u2014 an overview. In: Westphal M, Tonn JC, Ram Z. (eds) Local Therapies for Glioma Present Status and Future Developments. Acta Neurochirurgica Supplements. 2003;88:9\u201312. Vienna: Springer. https:\/\/doi.org\/10.1007\/978-3-7091-6090-9_3.","DOI":"10.1007\/978-3-7091-6090-9_3"},{"key":"239_CR13","doi-asserted-by":"crossref","unstructured":"Shaw EG, Wang M, Coons SW, et al. Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802[J]. J Clin Oncol. 2012;30(25):3065.","DOI":"10.1200\/JCO.2011.35.8598"},{"issue":"10","key":"239_CR14","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, Van Den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987\u201396. https:\/\/doi.org\/10.1056\/NEJMoa043330.","journal-title":"N Engl J Med"},{"issue":"29","key":"239_CR15","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1200\/JCO.19.02983","volume":"38","author":"EH Bell","year":"2020","unstructured":"Bell EH, Zhang P, Shaw EG, Buckner JC, Barger GR, Bullard DE, Mehta MP, Gilbert MR, Brown PD, Stelzer KJ, McElroy JP, Fleming J, Timmers CD, Becker AP, Salavaggione AL, Liu Z, Aldape K, Brachman DG, Gertler SZ, Murtha AD, Schultz CJ, Johnson D, Laack NN, Hunter GK, Crocker IR, Won M, Chakravarti A. Comprehensive genomic analysis in NRG oncology\/RTOG 9802: a phase III trial of radiation versus radiation plus procarbazine, lomustine (CCNU), and vincristine in high-risk low-grade glioma. J Clin Oncol. 2020;38(29):3407\u201317. https:\/\/doi.org\/10.1200\/JCO.19.02983.","journal-title":"J Clin Oncol"},{"issue":"5","key":"239_CR16","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-018-1913-0","volume":"136","author":"DJ Brat","year":"2018","unstructured":"Brat DJ, Aldape K, Colman H, Holland EC, Louis DN, Jenkins RB, Kleinschmidt-DeMasters BK, Perry A, Reifenberger G, Stupp R, von Deimling A, Weller M. cIMPACT-NOW update 3: recommended diagnostic criteria for \u201cDiffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV\u201d. Acta Neuropathol. 2018;136(5):805\u201310. https:\/\/doi.org\/10.1007\/s00401-018-1913-0.","journal-title":"Acta Neuropathol"}],"container-title":["Chinese Neurosurgical Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41016-021-00239-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s41016-021-00239-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41016-021-00239-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T04:13:09Z","timestamp":1617250389000},"score":1,"resource":{"primary":{"URL":"https:\/\/cnjournal.biomedcentral.com\/articles\/10.1186\/s41016-021-00239-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["239"],"URL":"https:\/\/doi.org\/10.1186\/s41016-021-00239-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-184357\/v1","asserted-by":"object"}]},"ISSN":["2057-4967"],"issn-type":[{"value":"2057-4967","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"assertion":[{"value":"1 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current study was approved by the Ethics Committee of Beijing Tiantan Hospital (KY2014-002-02).Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}